ShareValue scores for 600557.SHG: Valuation 69, Quality 57, Growth 33, Health 59.
600557.SHGSSE
Jiangsu Kanion Pharmaceutical Co Ltd
CN¥12.75
(+3.74%)
600557.SHGSSE
Jiangsu Kanion Pharmaceutical Co Ltd
CN¥12.75(+3.74%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
69
Fair Value
Price vs Value
Quality
57
Moderate
Business Strength
Growth
33
Weak
Revenue & Earnings
Health
59
Moderate
Financial Stability
Momentum
42
Neutral
Price Trend
Company Details
About
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China.
Market Cap$7.22B
P/E Ratio23.7
Dividend YieldNone
Sector Rank#1287
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026